Phase II study of erlotinib and docetaxel with concurrent intensity‐modulated radiotherapy in locally advanced head and neck squamous cell carcinoma期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Phase II study of erlotinib and docetaxel with concurrent intensity‐modulated radiotherapy in locally advanced head and neck squamous cell carcinoma

Authors:	Min Yao MD PhD Charles Woods MD Pierre Lavertu MD Pingfu Fu PhD Michael Gibson MD PhD Rod Rezaee MD Chad Zender MD Jay Wasman MD Neelesh Sharma MD PhD Mitchell Machtay MD Panayiotis Savvides MD PhD MPH

Affiliation:	1. Department of Radiation Oncology, University Hospitals Case Medical Center, Seidman Cancer Hospital, Cleveland, Ohio;2. Department of Otolaryngology – Head and Neck Surgery, University Hospitals Case Medical Center, Seidman Cancer Hospital, Cleveland, Ohio;3. Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio;4. Department of Internal Medicine (Medical Oncology), University Hospitals Case Medical Center, Seidman Cancer Hospital, Cleveland, Ohio;5. Department of Pathology, University Hospitals Case Medical Center, Seidman Cancer Hospital, Cleveland, Ohio

Abstract:

Keywords:	head and neck cancer radiation erlotinib docetaxel chemoradiation